Alessandra M. Bini, Ph.D.
Center to Reduce Cancer Health Disparities
National Cancer Institute
9609 Medical Center Drive, MSC 9746
Sixth Floor, West Tower, 6W240
Bethesda, MD 20852
phone: (240) 276-6179
fax: (240) 276-7862
Dr. Alessandra M. Bini is a Program Director in the Diversity Training Branch within the Center to Reduce Cancer Health Disparities (CRCHD) at the National Cancer Institute (NCI). In this role, she oversees funding mechanisms such as the Ruth L Kirschstein National Research Service Award Predoctoral Fellowship (F31) and the National Research Service Award Institutional Training Grants (T32) Supplements. In addition, she is involved in trans-NCI and trans-NIH activities.
From 2006 – 2010, Dr. Bini served as the Scientific Review Officer (SRO) for the Nuclear Dynamics and Transport (NDT) Study Section and for the Cell Biology and Development (F05) and Technology Development (F14) Fellowship Study Sections at the Center for Scientific Review (NIH/CSR). Earlier, she served as SRO in the review offices of the National Institute on Aging (NIA) and the National Heart, Lung and Blood Institute (NHLBI).
Prior to joining NIH in 2001, Dr. Bini was Associate Laboratory Member at the Lindsley F. Kimball Research Institute of the New York Blood Center (NYBC). Her research focused on the interaction of the matrix metalloproteinases system with the fibrinolytic system relevant in thrombosis, atherosclerosis, angiogenesis, and inflammation. She participated in the scientific review process for agencies such as the American Institute for Biological Sciences (AIBS, US Army) and the Department of Veterans Affairs Merit Review Boards.
Dr. Bini received her Ph.D. in Pathobiology and Molecular Medicine from Columbia University in New York for work on the role of thrombosis in the progression of human atherosclerosis. Previously, she obtained a Dr. Biol. Sci. degree from the University of Milano, Italy and trained and specialized in Pharmacology in the Thrombosis Laboratory at Mario Negri Institute, Milano, which pioneered new studies on the interaction between thrombosis and cancer and in the Thrombosis and Vascular Biology Center at the University of Leuven (Belgium). As part of her Dr. Biol. Sci. degree she studied behavioral-cognitive psychology and received further training in counseling at the Italian Association for Demographic Education. Dr. Bini was Head of the Coagulation and Fibrinolysis Research Unit at Consorzio Mario Negri Sud, Italy and a Visiting Scientist at the New York Blood Center.